SCHEMBL1210362

SCHEMBL1210362

CCN(C)C(=O)OCC1CCc2c(sc(NC(=O)C=Cc3ccco3)c2C#N)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.60
POLB P06746 4/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
MAPT P10636 4/20 0.60
LMNA P02545 3/20 0.60
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
HPGD P15428 3/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
KDM4E B2RXH2 2/20 0.60
NR0B1 P51843 1/20 0.60
PTPN5 P54829 1/20 0.52
EIF4H Q15056 1/20 0.45
GCGR P47871 2/20 0.43
HTT P42858 1/20 0.43
RECQL P46063 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FLT3 P36888 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1210049 0.93 ALDH1A1 (0.61) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1208599 0.93 ALDH1A1 (0.62) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1207614 0.92 ALDH1A1 (0.57) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1207381 0.92 ALDH1A1 (0.57) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1208226 0.90 ALDH1A1 (0.59) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1208038 0.90 ALDH1A1 (0.55) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1207254 0.90 ALDH1A1 (0.60) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1210216 0.89 ALDH1A1 (0.61) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1209371 0.88 ALDH1A1 (0.61) ALDH1A1POLBSMN1; SMN2MAPTLMNA
SCHEMBL1207610 0.88 ALDH1A1 (0.63) ALDH1A1POLBSMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD ALDH1A1 316/4885POLB 1250/4885SMN1; SMN2 2135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.